This classification system categorizes breast cancer into HER2+, luminal A (HER2-, ER+ and/or PR+), luminal B (HER2+, ER+ and/or PR+), and triple-negative breast cancer (basal-like) subtypes (4–6). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.